Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | | 786.2 |
| Cost of goods sold | 10.6 | 8.6 | | 1,221.9 |
| Gross profit | -10.6 | -8.6 | | -435.7 |
| Gross margin | | | | -55.4% |
| Selling, general and administrative | 57.6 | 28.0 | | 2,097.0 |
| Research and development | 1.4 | 0.6 | | |
| EBIT | -69.2 | -37.4 | | -4,105.2 |
| EBIT margin | | | | -522.1% |
| Pre-tax income | -77.5 | -53.0 | | -4,105.2 |
| Income taxes | 0.0 | 0.0 | | 0.0 |
| Tax rate | 0.0% | 0.0% | | 0.0% |
| Net income | -77.5 | -53.0 | | -4,105.2 |
| Net margin | | | | -522.1% |
| |
| Diluted EPS | ($0.75) | ($1.84) | | |
| Shares outstanding (diluted) | 102.9 | 28.7 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|